BioNeutra Global Corporation IEGH.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 87.12% | 66.76% | -- | -- | -- |
| Total Depreciation and Amortization | -55.34% | -1.14% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 434.38% | 147.71% | -- | -- | -- |
| Change in Net Operating Assets | -113.25% | -97.68% | -- | -- | -- |
| Cash from Operations | -137.39% | -132.15% | -- | -- | -- |
| Capital Expenditure | -624.75% | -161.05% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 95.71% | -- | -- | -- |
| Cash from Investing | -676.09% | -13.09% | -- | -- | -- |
| Total Debt Issued | 115.85% | 92.95% | -- | -- | -- |
| Total Debt Repaid | 5.11% | -43.70% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -201.66% | 13.67% | -- | -- | -- |
| Cash from Financing | 17.98% | 181.91% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 163.25% | 73.36% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -115.87% | 79.28% | -- | -- | -- |